New drugs.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use; D000068656:Mometasone Furoate; D000077205:Pioglitazone; D000069583:Pregabalin; D011244:Pregnadienediols / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D011244:Pregnadienediols; D045162:Thiazolidinediones; D000068656:Mometasone Furoate; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D008687:Metformin; D000077205:Pioglitazone